Department of Dermatology, Huangpu Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Acta Pharmacol Sin. 2012 Oct;33(10):1254-9. doi: 10.1038/aps.2012.84. Epub 2012 Sep 17.
To evaluate the effects of tanshinone IIA (Tan IIA), a lipophilic diterpene from the Chinese herb Salvia miltiorrhiza, on lipopolysaccharide (LPS)-induced disseminated intravascular coagulation (DIC) in rabbits.
LPS-induced DIC model was made in adult male New Zealand rabbits by continuous intravenous infusion of LPS (0.5 mg/kg) via marginal ear vein for 6 h. The animals were simultaneously administered with Tan IIA (1, 3 and 10 mg/kg) or heparin (500 000 IU/kg) through continuous infusion via the contralateral marginal ear vein for 6 h. Before and 2 and 6 h after the start of LPS infusion, blood samples were taken for biochemical analyses.
Continuous infusion of LPS into the rabbits gradually impaired the hemostatic parameters, damaged renal and liver functions, increased the plasma TNF-α level, and led to a high mortality rate (80%). Treatment of the rabbits with Tan IIA dose-dependently attenuated the increase in activated partial thromboplastin time (APTT), prothrombin time (PT) and fibrin-fibrinogen degradation products (FDP); ameliorated the decrease in plasma levels of fibrinogen and platelets; and reversed the decline in activity of protein C and antithrombin III. Meanwhile, the treatment significantly suppressed the increase in the plasma levels of aminotransferase, creatinine and TNF-α, and led to much lower mortality (46.7% and 26.7% for the medium- and high-dose groups). Treatment of the rabbits with the high dose of heparin also effectively improved the hemostatic parameters, ameliorated liver and renal injuries, and reduced the plasma level of TNF-α, and significantly reduced the mortality (33.3%).
Tan IIA exerts a protective effect against DIC in rabbits.
评价丹参酮Ⅱ A(Tan IIA),一种来自中国草药丹参的亲脂二萜,对脂多糖(LPS)诱导的兔弥散性血管内凝血(DIC)的影响。
通过耳缘静脉持续输注 LPS(0.5mg/kg)6 小时,建立成年雄性新西兰兔 LPS 诱导的 DIC 模型。同时通过对侧耳缘静脉持续输注 Tan IIA(1、3 和 10mg/kg)或肝素(50 万 IU/kg)6 小时。在 LPS 输注前和输注后 2 和 6 小时取血进行生化分析。
LPS 持续输注入兔体内,逐渐损害止血参数,损伤肝肾功能,增加血浆 TNF-α 水平,导致高死亡率(80%)。Tan IIA 剂量依赖性地减轻了活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)和纤维蛋白-纤维蛋白原降解产物(FDP)的增加;改善了血浆纤维蛋白原和血小板水平的降低;并逆转了蛋白 C 和抗凝血酶 III 活性的下降。同时,该治疗显著抑制了血浆转氨酶、肌酐和 TNF-α 水平的升高,死亡率显著降低(中剂量组和高剂量组分别为 46.7%和 26.7%)。高剂量肝素治疗也能有效改善止血参数,改善肝肾功能损伤,降低 TNF-α 血浆水平,显著降低死亡率(33.3%)。
Tan IIA 对兔 DIC 具有保护作用。